Clinical Trial Update: Atomoxetine vs Placebo in the Treatment of ADHD in Swedish Children and Adolescents [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating atomoxetine against placebo for ADHD in Swedish children and adolescents has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• STRATTERA (Atomoxetine hydrochloride)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Attention Deficit Hyperactivity Disorder | Phase 3 | Status: COMPLETED